TuesdayJul 07, 2026 10:00 am

France to Relaunch its Social Leasing EV Program in July

France will relaunch the country’s social leasing electric vehicle (EV) program on July 16, 2026 as part of its effort to make electric cars more affordable for lower-income workers. The program is designed to help people who rely on private vehicles for work but cannot afford the high upfront cost of buying a new EV. Instead of purchasing a car, eligible drivers can lease one at a monthly cost of less than €200 ($228), making cleaner transportation more accessible. The program is available across Metropolitan France, the country's overseas departments and regions, and Saint-Pierre-et-Miquelon. It focuses on helping workers who…

Continue Reading

MondayJul 06, 2026 10:00 am

South Korea Earmarks $1 Trillion for Chip, AI Investment

South Korea has announced one of its biggest technology investment plans ever. The country plans to spend more than $1 trillion over the coming years to strengthen its leadership in semiconductor chips and artificial intelligence (AI). The government believes this investment is necessary to stay ahead in the fast-growing global technology industry. President Lee Jae Myung introduced the plan as a major step toward securing South Korea's future. He said the country must move faster than other nations in developing the key technologies that will shape the world. The strategy focuses on three main areas: semiconductor chips, physical AI, and…

Continue Reading

ThursdayJul 02, 2026 10:00 am

Why Wall Street Watches Jefferies’ Earnings Reports Closely

Jefferies Financial may not be as large as Wall Street giants like Goldman Sachs, Morgan Stanley, or JPMorgan Chase, but its earnings reports attract plenty of attention. Many investors and market analysts watch the company's financial results because they often provide an early look at how the investment banking industry is performing. Since Jefferies reports its earnings weeks before the biggest U.S. banks, its results can offer useful clues about what may happen when those larger institutions announce their own quarterly performance. One reason Jefferies is closely followed is that its financial quarter ends earlier than those of many major…

Continue Reading

WednesdayJul 01, 2026 10:40 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial capital to preclinical and early-stage innovation. The Jazz Pharmaceuticals–AbCellera collaboration illustrates how differentiated antibody technologies can command significant financial commitments before entering clinical development. VERAXA Biotech AG is positioning its technology platform across both ADCs and T-cell engagers, two therapeutic modalities that continue to attract strategic partnerships and acquisitions. Platform technologies and individual drug candidates both represent potential avenues for future partnering, licensing, and collaboration agreements. Recent transactions across the sector demonstrate that pharmaceutical companies are actively seeking access to…

Continue Reading

TuesdayJun 30, 2026 10:00 am

China-Made Sodium Battery Surprisingly Matches Tesla Battery Standards

A new study has revealed that a sodium-ion battery made by Chinese manufacturer Hina has achieved performance levels that are closer than expected to those of Tesla’s lithium-ion batteries. The findings have attracted attention because sodium-ion technology has long been viewed as a lower-cost alternative that still had a significant gap to close before competing with leading battery technologies. The research was carried out by scientists from RWTH Aachen University in Germany. They examined 120 commercial sodium-ion battery cells to better understand their design, quality, and performance. The team used advanced testing methods to measure how the batteries performed under…

Continue Reading

FridayJun 26, 2026 10:00 am

Money Seems to Be Shifting from Bitcoin to XRP

Money in the crypto market often moves in patterns that can look dramatic at first glance. Recently, ETF flow data has created a strong narrative that money may be shifting from Bitcoin to XRP. But while there is some truth to this idea, the full picture is more balanced and less extreme than it sounds. In recent weeks, Bitcoin exchange-traded funds have seen significant outflows. One report showed that around $1.44 billion left Bitcoin ETFs in a single week, continuing a broader trend of institutional investors reducing exposure to Bitcoin funds. Ethereum ETFs have also experienced similar outflows, suggesting that…

Continue Reading

ThursdayJun 25, 2026 10:00 am

EU Considers Imposing Tariffs on Chinese PHEVs

The European Union is reportedly considering new tariffs on plug-in hybrid electric vehicles (PHEVs) imported from China. The move comes as European officials continue to examine the growing presence of Chinese automakers in the region and the impact their vehicles may have on local manufacturers. China has become the world's leading market for electric vehicles and other plug-in vehicles. The country accounts for a large share of global electric vehicle sales, and demand for cleaner transportation continues to rise. Thanks to massive production volumes and intense competition among manufacturers, Chinese automakers have been able to lower production costs and offer…

Continue Reading

WednesdayJun 24, 2026 11:15 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology, demonstrating selective activity against cancer cells while sparing healthy cells in early testing. The company is presenting its BiTAC-ADC and BiTAC-TCE platforms for potential strategic collaborations at the BIO International Convention 2026. VERAXA’s proprietary BiTAC approach is designed to improve the precision of antibody-based cancer therapies by activating therapeutic effects only in targeted tumor cells. The company maintains a diversified oncology pipeline of antibody-based formats including antibody-drug conjugates (“ADCs”), T-cell engagers (“TCEs”),  and other antibody-based formats. VERAXA recently began trading on the NASDAQ Capital Market under the…

Continue Reading

TuesdayJun 23, 2026 10:00 am

Binance Could Lose Access to EU Market as MiCA Deadline Approaches

Binance, one of the world's largest cryptocurrency exchanges, is facing uncertainty in Europe as a key regulatory deadline draws closer. Reports suggest that the company's application for a license under the European Union's Markets in Crypto-Assets (MiCA) framework may be rejected in Greece. If that happens and Binance fails to secure approval elsewhere, it could lose the ability to offer its services across the EU starting in July. The MiCA framework was created by the European Union to establish clear and consistent rules for cryptocurrency companies operating within member states. The goal is to improve transparency, strengthen consumer protection, and…

Continue Reading

MondayJun 22, 2026 10:00 am

Study Finds That AI is Eroding Ecommerce Shoppers’ Trust

Artificial intelligence is changing the way people shop online. Businesses are using AI to improve customer service, create product descriptions, recommend products, and automate many parts of ecommerce. While these tools can make shopping more convenient, a new study suggests that AI is also creating new concerns for consumers. As AI becomes more common, many shoppers are finding it harder to know which online stores and product information they can trust. According to TrustedSite's 2026 State of Ecommerce Trust report, trust has become a major issue in online shopping. The survey, which included 1,295 consumers in the United States, found…

Continue Reading

Contact us: (512) 354-7000